US Stock MarketDetailed Quotes

Aprea Therapeutics (APRE)

Watchlist
  • 0.9124
  • +0.0281+3.18%
Trading Apr 24 12:49 ET
10.93MMarket Cap-0.47P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aprea Therapeutics (APRE) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-36.11%14.6M
-36.11%14.6M
-47.74%13.72M
-42.39%16.53M
-40.45%19.28M
5.75%22.85M
5.75%22.85M
3.53%26.25M
3.65%28.69M
4.43%32.37M
-Cash and cash equivalents
-36.11%14.6M
-36.11%14.6M
-47.74%13.72M
-42.39%16.53M
-40.45%19.28M
5.75%22.85M
5.75%22.85M
3.53%26.25M
3.65%28.69M
4.43%32.37M
Other current assets
32.45%961.9K
32.45%961.9K
-3.53%225.94K
-54.34%395.01K
-20.06%558.69K
-20.57%726.25K
-20.57%726.25K
-18.19%234.2K
-9.29%865.09K
-31.67%698.86K
Total current assets
-34.00%15.56M
-34.00%15.56M
-47.35%13.94M
-42.74%16.93M
-40.02%19.83M
4.68%23.58M
4.68%23.58M
3.29%26.48M
3.22%29.56M
3.28%33.07M
Non current assets
Net PPE
-26.64%59.81K
-26.64%59.81K
-24.97%65.24K
-23.51%70.67K
-15.62%76.09K
-7.74%81.52K
-7.74%81.52K
0.87%86.95K
5,375.93%92.38K
4,616.68%90.18K
-Gross PPE
0.00%153.96K
0.00%153.96K
-24.97%65.24K
--70.67K
--76.09K
11.18%153.96K
11.18%153.96K
--86.95K
----
----
-Accumulated depreciation
-29.98%-94.16K
-29.98%-94.16K
----
----
----
-44.53%-72.44K
-44.53%-72.44K
----
----
----
Other non current assets
-2.95%312.35K
-2.95%312.35K
-3.44%312.09K
-0.19%311.84K
660.21%311.58K
690.41%321.83K
690.41%321.83K
699.03%323.2K
677.56%312.42K
--40.99K
Total non current assets
-7.73%372.16K
-7.73%372.16K
-8.00%377.33K
-5.51%382.5K
195.55%387.67K
212.49%403.35K
212.49%403.35K
223.85%410.15K
866.87%404.8K
6,760.30%131.17K
Total assets
-33.55%15.93M
-33.55%15.93M
-46.75%14.32M
-42.23%17.31M
-39.09%20.22M
5.87%23.98M
5.87%23.98M
4.38%26.89M
4.48%29.96M
3.68%33.2M
Liabilities
Current liabilities
Payables
-47.22%713.67K
-47.22%713.67K
-44.42%641.32K
24.01%1.2M
-2.79%1.28M
-19.05%1.35M
-19.05%1.35M
33.78%1.15M
-14.75%964.33K
59.61%1.32M
-accounts payable
-47.22%713.67K
-47.22%713.67K
-44.42%641.32K
24.01%1.2M
-2.79%1.28M
-19.05%1.35M
-19.05%1.35M
33.78%1.15M
-14.75%964.33K
59.61%1.32M
Current accrued expenses
-17.08%1.28M
-17.08%1.28M
-19.78%1.45M
3.64%1.55M
39.35%1.69M
32.02%1.54M
32.02%1.54M
-20.07%1.81M
-3.07%1.5M
-27.48%1.21M
Current deferred liabilities
----
----
----
----
----
--0
--0
--0
--50.74K
--148.41K
Current liabilities
-17.75%2.76M
-17.75%2.76M
-26.26%2.68M
2.37%3.17M
13.36%3.36M
-23.36%3.36M
-23.36%3.36M
-12.73%3.64M
-21.68%3.09M
-29.86%2.97M
Non current liabilities
Preferred securities outside stock equity
-44.52%727.36K
-44.52%727.36K
-44.52%727.36K
-44.52%727.36K
0.00%1.31M
0.00%1.31M
0.00%1.31M
0.00%1.31M
0.00%1.31M
0.00%1.31M
Total non current liabilities
-44.52%727.36K
-44.52%727.36K
-44.52%727.36K
-44.52%727.36K
0.00%1.31M
0.00%1.31M
0.00%1.31M
0.00%1.31M
0.00%1.31M
0.00%1.31M
Total liabilities
-25.26%3.49M
-25.26%3.49M
-31.10%3.41M
-11.58%3.9M
9.26%4.67M
-17.99%4.67M
-17.99%4.67M
-9.68%4.95M
-16.28%4.41M
-22.79%4.28M
Shareholders'equity
Share capital
49.46%8.19K
49.46%8.19K
10.01%5.98K
5.93%5.75K
1.53%5.51K
46.71%5.48K
46.71%5.48K
45.48%5.44K
45.54%5.43K
45.54%5.43K
-common stock
49.46%8.19K
49.46%8.19K
10.01%5.98K
5.93%5.75K
1.53%5.51K
46.71%5.48K
46.71%5.48K
45.48%5.44K
45.54%5.43K
45.54%5.43K
Retained earnings
-3.92%-333.64M
-3.92%-333.64M
-4.10%-331.19M
-4.41%-328.21M
-4.53%-324.97M
-4.21%-321.04M
-4.21%-321.04M
-4.43%-318.15M
-4.29%-314.36M
-4.26%-310.89M
Paid-in capital
1.64%356.71M
1.64%356.71M
0.58%352.72M
0.49%352.25M
0.20%351.15M
4.57%350.97M
4.57%350.97M
4.51%350.69M
4.49%350.55M
4.54%350.44M
Gains losses not affecting retained earnings
-0.07%-10.63M
-0.07%-10.63M
-0.23%-10.63M
-0.00%-10.63M
-0.00%-10.63M
-0.15%-10.63M
-0.15%-10.63M
0.29%-10.6M
0.06%-10.63M
-0.61%-10.63M
Total stockholders'equity
-35.56%12.44M
-35.56%12.44M
-50.28%10.91M
-47.52%13.41M
-46.24%15.55M
13.88%19.31M
13.88%19.31M
8.17%21.95M
9.14%25.56M
9.22%28.92M
Total equity
-35.56%12.44M
-35.56%12.44M
-50.28%10.91M
-47.52%13.41M
-46.24%15.55M
13.88%19.31M
13.88%19.31M
8.17%21.95M
9.14%25.56M
9.22%28.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -36.11%14.6M-36.11%14.6M-47.74%13.72M-42.39%16.53M-40.45%19.28M5.75%22.85M5.75%22.85M3.53%26.25M3.65%28.69M4.43%32.37M
-Cash and cash equivalents -36.11%14.6M-36.11%14.6M-47.74%13.72M-42.39%16.53M-40.45%19.28M5.75%22.85M5.75%22.85M3.53%26.25M3.65%28.69M4.43%32.37M
Other current assets 32.45%961.9K32.45%961.9K-3.53%225.94K-54.34%395.01K-20.06%558.69K-20.57%726.25K-20.57%726.25K-18.19%234.2K-9.29%865.09K-31.67%698.86K
Total current assets -34.00%15.56M-34.00%15.56M-47.35%13.94M-42.74%16.93M-40.02%19.83M4.68%23.58M4.68%23.58M3.29%26.48M3.22%29.56M3.28%33.07M
Non current assets
Net PPE -26.64%59.81K-26.64%59.81K-24.97%65.24K-23.51%70.67K-15.62%76.09K-7.74%81.52K-7.74%81.52K0.87%86.95K5,375.93%92.38K4,616.68%90.18K
-Gross PPE 0.00%153.96K0.00%153.96K-24.97%65.24K--70.67K--76.09K11.18%153.96K11.18%153.96K--86.95K--------
-Accumulated depreciation -29.98%-94.16K-29.98%-94.16K-------------44.53%-72.44K-44.53%-72.44K------------
Other non current assets -2.95%312.35K-2.95%312.35K-3.44%312.09K-0.19%311.84K660.21%311.58K690.41%321.83K690.41%321.83K699.03%323.2K677.56%312.42K--40.99K
Total non current assets -7.73%372.16K-7.73%372.16K-8.00%377.33K-5.51%382.5K195.55%387.67K212.49%403.35K212.49%403.35K223.85%410.15K866.87%404.8K6,760.30%131.17K
Total assets -33.55%15.93M-33.55%15.93M-46.75%14.32M-42.23%17.31M-39.09%20.22M5.87%23.98M5.87%23.98M4.38%26.89M4.48%29.96M3.68%33.2M
Liabilities
Current liabilities
Payables -47.22%713.67K-47.22%713.67K-44.42%641.32K24.01%1.2M-2.79%1.28M-19.05%1.35M-19.05%1.35M33.78%1.15M-14.75%964.33K59.61%1.32M
-accounts payable -47.22%713.67K-47.22%713.67K-44.42%641.32K24.01%1.2M-2.79%1.28M-19.05%1.35M-19.05%1.35M33.78%1.15M-14.75%964.33K59.61%1.32M
Current accrued expenses -17.08%1.28M-17.08%1.28M-19.78%1.45M3.64%1.55M39.35%1.69M32.02%1.54M32.02%1.54M-20.07%1.81M-3.07%1.5M-27.48%1.21M
Current deferred liabilities ----------------------0--0--0--50.74K--148.41K
Current liabilities -17.75%2.76M-17.75%2.76M-26.26%2.68M2.37%3.17M13.36%3.36M-23.36%3.36M-23.36%3.36M-12.73%3.64M-21.68%3.09M-29.86%2.97M
Non current liabilities
Preferred securities outside stock equity -44.52%727.36K-44.52%727.36K-44.52%727.36K-44.52%727.36K0.00%1.31M0.00%1.31M0.00%1.31M0.00%1.31M0.00%1.31M0.00%1.31M
Total non current liabilities -44.52%727.36K-44.52%727.36K-44.52%727.36K-44.52%727.36K0.00%1.31M0.00%1.31M0.00%1.31M0.00%1.31M0.00%1.31M0.00%1.31M
Total liabilities -25.26%3.49M-25.26%3.49M-31.10%3.41M-11.58%3.9M9.26%4.67M-17.99%4.67M-17.99%4.67M-9.68%4.95M-16.28%4.41M-22.79%4.28M
Shareholders'equity
Share capital 49.46%8.19K49.46%8.19K10.01%5.98K5.93%5.75K1.53%5.51K46.71%5.48K46.71%5.48K45.48%5.44K45.54%5.43K45.54%5.43K
-common stock 49.46%8.19K49.46%8.19K10.01%5.98K5.93%5.75K1.53%5.51K46.71%5.48K46.71%5.48K45.48%5.44K45.54%5.43K45.54%5.43K
Retained earnings -3.92%-333.64M-3.92%-333.64M-4.10%-331.19M-4.41%-328.21M-4.53%-324.97M-4.21%-321.04M-4.21%-321.04M-4.43%-318.15M-4.29%-314.36M-4.26%-310.89M
Paid-in capital 1.64%356.71M1.64%356.71M0.58%352.72M0.49%352.25M0.20%351.15M4.57%350.97M4.57%350.97M4.51%350.69M4.49%350.55M4.54%350.44M
Gains losses not affecting retained earnings -0.07%-10.63M-0.07%-10.63M-0.23%-10.63M-0.00%-10.63M-0.00%-10.63M-0.15%-10.63M-0.15%-10.63M0.29%-10.6M0.06%-10.63M-0.61%-10.63M
Total stockholders'equity -35.56%12.44M-35.56%12.44M-50.28%10.91M-47.52%13.41M-46.24%15.55M13.88%19.31M13.88%19.31M8.17%21.95M9.14%25.56M9.22%28.92M
Total equity -35.56%12.44M-35.56%12.44M-50.28%10.91M-47.52%13.41M-46.24%15.55M13.88%19.31M13.88%19.31M8.17%21.95M9.14%25.56M9.22%28.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +18.15%
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +11.34%
4
VanEck Oil Services ETF
OIH
+5.67%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+3.89%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.66%
Sample Name
Sample Code
 +12.66%
Sample Name
Sample Code
 +9.54%
4
United Microelectronics
UMC
+5.02%
5
Atour Lifestyle Holdings
ATAT
+4.63%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of a restart in the second round of US-Iran talks have emerged, with the New York Post citing sources indicating that Iran's foreign m Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -